✦ LIBER ✦

Phase II Evaluation of Oral Estramustine, Oral Etoposide, and Intravenous Paclitaxel in Patients with Hormone-Sensitive Prostate Adenocarcinoma

✍ Scribed by Niklas J. Mackler; Kenneth J. Pienta; Rodney L. Dunn; Kathleen A. Cooney; Bruce G. Redman; Karin B. Olson; Judith E. Fardig; David C. Smith

Book ID: 119935401
Publisher: CIG Media Group, LP.
Year: 2007
Tongue: English
Weight: 127 KB
Volume: 5
Category: Article
ISSN: 1558-7673
DOI: 10.3816/cgc.2007.n.010

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II Evaluation of Early Oral Estram

Phase II Evaluation of Early Oral Estramustine, Oral Etoposide, and Intravenous Paclitaxel Combined With Hormonal Therapy in Patients With High-risk Metastatic Prostate Adenocarcinoma: Southwest Oncology Group S0032

✍ David C. Smith; Cathy M. Tangen; Peter J. Van Veldhuizen Jr.; Grant W. Harrer; A 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 233 KB

A phase ii trial of oral estramustine an

A phase ii trial of oral estramustine and oral etoposide in hormone refractory prostate cancer

✍ Kenneth J. Pienta; Bruce G. Redman; Rajesh Bandekar; Myla Strawderman; Kemp Ceas 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 750 KB

Phase II trial of paclitaxel, estramusti

Phase II trial of paclitaxel, estramustine, etoposide, and carboplatin in the treatment of patients with hormone-refractory prostate carcinoma

✍ David C. Smith; Christopher H. Chay; Rodney L. Dunn; Jude Fardig; Peg Esper; Kar 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 127 KB 👁 1 views

## Abstract ## BACKGROUND Preclinical data suggest that the combination of intravenous (i.v.) paclitaxel, carboplatin, oral etoposide, and oral estramustine (TEEC) has significant activity in patients with advanced, hormone‐refractory prostate carcinoma. The authors conducted this clinical trial t

Monthly paclitaxel and carboplatin with

Monthly paclitaxel and carboplatin with oral estramustine phosphate in patients with hormone-refractory prostate cancer

✍ Takehiko Segawa; Toshiyuki Kamoto; Hidefumi Kinoshita; Yasuharu Kunishima; Koji 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 378 KB

Phase I trial of weekly paclitaxel plus

Phase I trial of weekly paclitaxel plus oral estramustine phosphate in patients with hormone-refractory prostate cancer

✍ Naomi Haas; Bruce Roth; Carlos Garay; Gwen Yeslow; Michael Entmacher; Alan Weins 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 174 KB

Oral estramustine plus oral etoposide in

Oral estramustine plus oral etoposide in the treatment of hormone refractory prostate cancer patients: A phase II study with a 5-year follow-up

✍ Alfredo Berruti; Enrica Fara; Marcello Tucci; Roberto Tarabuzzi; Alessandra Mosc 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 163 KB